Garmin (GRMN) Form 144 Files Proposed 10,202-Share Sale on NYSE

Rhea-AI Filing Summary

Form 144 notice for Garmin Ltd (GRMN) records a proposed sale of 10,202 common shares through UBS Financial Services Inc on the NYSE with an aggregate market value of $2,371,674.02 and total shares outstanding listed as 192,493,945. The filing lists the securities being sold as acquired in annual restricted stock releases on 12/15 of 2020, 2021, 2022, 2023 and 2024, with respective amounts of 1,483, 2,391, 1,915, 2,153 and 2,260 shares. The form reports no securities sold by the account in the past three months and includes the required representation that the seller does not possess undisclosed material adverse information.

Positive

• Proposed sale fully disclosed with broker, share count, aggregate market value and exchange specified
• Acquisition history provided showing the shares originated from annual restricted stock releases (2020-2024) with exact share counts
• No sales reported by the same account in the past three months, as stated in the filing
• Standard attestation included that the seller does not possess undisclosed material adverse information

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice only; provides specifics on shares, broker and acquisition history without new operational disclosures.

The filing is a standard Form 144 notifying the market of a proposed sale of 10,202 common shares through UBS Financial Services on the NYSE, showing the aggregate market value and listing the shares outstanding. The document documents that the shares originated from annual restricted stock releases between 2020 and 2024 and confirms no sales in the prior three months. From a market-moving perspective, the filing itself is a compliance disclosure rather than a disclosure of operational or financial developments.

Corporate Governance Expert

TL;DR: Compliance-focused filing that traces grant origin and affirms absence of undisclosed material information.

The notice supplies broker details and acquisition dates for the securities to be sold, which supports transparency around insider liquidity. It also contains the standard attestation that the seller is not aware of undisclosed material adverse information. There are no indications in the filing of unusual vesting patterns, related-party transfers, or recent sales by the same account within three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	10202	2371674.02	192493945	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	12/15/2020	Restricted stock release	issuer			1483	12/15/2020	n/a
common	12/15/2021	Restricted stock release	issuer			2391	12/15/2021	n/a
common	12/15/2022	restricted stock release	issuer			1915	12/15/2022	n/a
common	12/15/2023	Restricted stock release	issuer			2153	12/15/2023	n/a
common	12/15/2024	Restricted stock release	issuer			2260	12/15/2024	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Garmin Ltd's (GRMN) Form 144 disclose?

The Form 144 discloses a proposed sale of 10,202 common shares via UBS Financial Services on the NYSE with an aggregate market value of $2,371,674.02.

When is the proposed sale scheduled to occur for the shares reported on the Form 144?

The filing lists the approximate date of sale as 08/27/2025.

How were the shares being sold by GRMN acquired?

The shares were acquired through restricted stock releases on 12/15 of each year from 2020 through 2024, with specified share amounts for each year.

Did the filer sell any GRMN securities in the past three months according to the Form 144?

No; the filing explicitly states "Nothing to Report" for securities sold during the past three months.

Which broker is handling the proposed sale in the Form 144?

The broker named is UBS Financial Services Inc, 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ 07086.